North America Allergy Immunotherapies Market Trends and Analysis by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

North America Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Geography

Report Date : Sep 2020
Report Code : TIPRE00014185

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 95

Page Updated: Dec 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The North America allergy immunotherapies market was valued at US$ 697.53 million in 2019 and is projected to reach US$ 1,634.17 million by 2027; it is expected to grow at a CAGR of 11.3% during the forecast period.

This can be attributed to the growing developments in the healthcare sector due to R and D activities in this industry. The increasing initiatives taken by various research institutes and organizations for improving medical facilities and services are further leading to North America Allergy Immunotherapies market growth.

Allergen immunotherapy is a medical treatment useful for environmental allergies, allergies to insect bites, and asthma. According to the American Academy of Allergy, Asthma, and Immunology (AAAAI), nearly 7.8% of people aged 18 years and above in the U.S. have allergy rhinitis. Worldwide, around 30% of the total population is affected by hay fever annually. Thus, growing infection rates and the adoption of advanced treatment methods will favorably impact allergy immunotherapy market revenue share over the upcoming years. Positive clinical results of various immunotherapies, which are undergoing clinical trials, support the development of allergy immunotherapy-based drugs. Firms are adopting business expansion strategies and collaborations and new product development to increase their market footprint. This strategy will help the company in strengthening its market position by geographical expansion.

The Covid-19 pandemic has harmed allergy immunotherapies market size, with small and medium scale companies struggling to sustain their businesses in the near-term future. Industry leaders are now focusing on creating new business practices to deal with crises like covid-19 pandemic.

North America Allergy Immunotherapies Market Revenue and Forecast to 2027 (US$ Mn)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION

North America Allergy Immunotherapies Market – By Treatment

Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)

North America Allergy Immunotherapies Market – By Allergy Type

Allergic Rhinitis
Asthma
Food Allergy
Venom Allergy
Others

North America Allergy Immunotherapies Market – By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

North America Allergy Immunotherapies Market – By Country

United States
Canada
Mexico

Company Profiles

Johnson and Johnson Services, Inc.
ALK Abello A/S
Aimmune Therapeutics
Anergis
Circassia

North America Allergy Immunotherapies Report Scope

Report Attribute	Details
Market size in 2019	US$ 697.53 Million
Market Size by 2027	US$ 1,634.17 Million
Global CAGR (2019 - 2027)	11.3%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Treatment Subcutaneous Immunotherapy Sublingual Immunotherapy By Allergy type Allergic Rhinitis Asthma Food Allergy Venom Allergy By Distribution Channel Hospital Pharmacy Retail Pharmacy Online Pharmacy
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	Johnson and Johnson Services, Inc. ALK Abello A/S Aimmune Therapeutics Anergis Circassia

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North America Allergy Immunotherapies Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy